Bio Path reported $3.55M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Baxter International BAX:US USD 3.7B 2.88B
Bio Path BPTH:US USD 3.55M 536K
Karyopharm Therapeutics KPTI:US USD 67.45M 465K
Seattle Genetics SGEN:US USD 682.15M 20.95M
Spectrum Pharmaceuticals SPPI:US USD 21.6M 3.79M